MRI-based volumetric differentiation of sporadic cerebellar ataxia.

The term idiopathic cerebellar ataxia (IDCA) designates a variety of cerebellar syndromes that may present with a purely cerebellar syndrome (IDCA-C) or with additional extracerebellar features (IDCA-P). Multiple system atrophy is also a sporadic neurodegenerative disorder of unknown origin that may cause prominent cerebellar symptoms (MSA-C). The final neuropathological answer to the question whether IDCA-P and MSA-C represent different varieties of one disease or two distinct entities is still lacking. Three-dimensional MRI-based volumetry allows morphological investigations intra vitam. Volumetric analysis of cerebellum, brainstem and basal ganglia was therefore performed in 46 patients with sporadic cerebellar ataxia and 16 age-matched healthy controls. Patients with dementia were excluded from the study since cognitive impairment is an exclusion criterion for the diagnosis of MSA. Cerebellar patients were clinically divided into two groups: 33 patients with multiple system atrophy with prominent cerebellar symptoms (MSA-C) and 13 patients with extracerebellar features not corresponding to MSA-C (IDCA-P). There was evidence for substantial cerebellar atrophy in both cerebellar groups while additional brainstem atrophy was significantly more pronounced in MSA-C patients. Absolute caudate and putamen atrophy was found to be restricted to single MSA-C individuals while group comparisons of mean volumes did not yield significant differences from controls. Based on the volumetric data, diagnosis could be correctly predicted in 94% of control, 82% of MSA-C and 100% of IDCA-P individuals. The finding of specific imaging characteristics strengthens (i) the value of MRI volumetry in separating MSA-C from other types of sporadic cerebellar ataxia, and (ii) the hypothesis of two independent neurodegenerative disorders in MSA-C and IDCA-P.

[1]  S. Gilman,et al.  Evolution of sporadic olivopontocerebellar atrophy into multiple system atrophy , 2000, Neurology.

[2]  I Litvan,et al.  Consensus statement on the diagnosis of multiple system atrophy , 1998, Journal of the Neurological Sciences.

[3]  C. Marsden,et al.  Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy , 1995, Annals of neurology.

[4]  C. Marsden,et al.  The value of urethral sphincter electromyography in the differential diagnosis of parkinsonism. , 1989, British journal of urology.

[5]  M. Skalej,et al.  Magnetic resonance imaging–based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy , 1999, Annals of neurology.

[6]  J. Dichgans,et al.  Idiopathic cerebellar ataxia of late onset: natural history and MRI morphology. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[7]  P. Lantos,et al.  The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. , 1994, Brain : a journal of neurology.

[8]  P. Lantos,et al.  Cellular pathology of multiple system atrophy: a review. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[9]  S. Gilman,et al.  The relationship of multiple system atrophy to sporadic olivopontocerebellar atrophy and other forms of idiopathic late‐onset cerebellar atrophy , 1996, Neurology.

[10]  Georg Auburger,et al.  Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2 , 1996, Nature Genetics.

[11]  U Klose,et al.  Reliability and exactness of MRI‐based volumetry: A phantom study , 1996, Journal of magnetic resonance imaging : JMRI.

[12]  P. Patel,et al.  Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion , 1996, Science.

[13]  Richard S. J. Frackowiak,et al.  Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C‐raclopride and positron emission tomography , 1992, Annals of neurology.

[14]  Huda Y. Zoghbi,et al.  Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1 , 1993, Nature Genetics.

[15]  J. Penney Multiple systems atrophy and nonfamilial olivopontocerebellar atrophy are the same disease , 1995, Annals of neurology.

[16]  J. Palace,et al.  Value of sphincter electromyography in the diagnosis of multiple system atrophy , 1997, Muscle & nerve.

[17]  William B. Dobyns,et al.  Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channel , 1997, Nature Genetics.

[18]  S. Daniel,et al.  Differences between multiple system atrophy and olivopontocerebellar atrophy , 1996, Annals of Neurology.

[19]  J. Dichgans,et al.  Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[20]  M. Skalej,et al.  A new semiautomated, three‐dimensional technique allowing precise quantification of total and regional cerebellar volume using MRI , 1998, Magnetic resonance in medicine.

[21]  Shigenobu Nakamura,et al.  CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1 , 1994, Nature Genetics.

[22]  Peter L. Lantos,et al.  Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome) , 1989, Journal of the Neurological Sciences.

[23]  A J Lees,et al.  Clinical usefulness of magnetic resonance imaging in multiple system atrophy , 1998, Journal of neurology, neurosurgery, and psychiatry.

[24]  C. Fowler,et al.  Genitourinary dysfunction in multiple system atrophy: clinical features and treatment in 62 cases. , 1994, The Journal of urology.

[25]  Carlo Colosimo,et al.  Multiple system atrophy , 2004, The Lancet Neurology.